UPCOMING LIVE WEBINAR

The R&D Tax Credit in the Pharmaceutical and Life Science Industries

Date & Time: Monday, December 8, 2025 at 1:00pm CT | Duration: 60 Minutes

R&D Tax Credits: 80% of companies that qualify don’t claim! Every year, companies throw away thousands or even hundreds of thousands of dollars because of simple misunderstandings surrounding the research and development (R&D) tax credit. Amendment claims can go back three years and in most situations produce sizable refunds for past R&D activities.

WEBINAR DETAILS

Title: The R&D Tax Credit in the Pharmaceutical and Life Sciences Industries

Date: Monday, December 8, 2025

Time: 1:00 pm – 2:00 pm Central Time

Cost: FREE

Learning objectives include:

An overview of R&D Tax Credits
Identify Qualifying Research Activities
Define the 4-Part Test
How to substantiate activities through documentation
Identify Qualifying Research Expenses

CE/CPE credits: Worth one hour

Knowledge Level: Basic*

Field of Study: Taxation

Join the Webinar Here

Youtube Channel

Ask a Question Here

Click Here to Access the Participation Form

Click Here to Contact Technical Team

Why Choose Us

We are certified to the ISO31000:2009 Risk Management standard
We are NASBA certified and provide daily CPE credits to CPAs, CFPs, and SMBs
We are an IRS approved Continuing Education provider for CPAs and Enrolled Agents
We have an rated A+ with the Better Businese Beureau
Our R&D tax audit insurance product, creditARMOR is one of the most cost effective tools on the market
Our AI language model, TaxTrex prepares R&D tax credit claims in less than 90 minutes.
Each R&D tax claims prepared by Swanson Reed undergo a six eye review by a Qualified Engineer, Scientist and Enrolled Agent or CPA.

Logos-to-use

Schedule a Teleconference

Small businesses in the pharmaceutical industry can significantly benefit from the Research and Development tax credit, turning their innovative efforts into substantial tax savings. This credit directly reduces federal tax liability, freeing up capital that can be reinvested in further research, development of new drugs, medical devices, or improved manufacturing processes. Crucially, eligible startups and pre-revenue companies can utilize the Research and Development payroll tax offset, which allows them to apply a portion of their Research and Development credit against their employer’s share of FICA payroll taxes. This immediate cash benefit directly offsets payroll costs, providing vital liquidity for young companies often operating at a loss while pursuing groundbreaking pharmaceutical advancements.

Are you eligible?

Why choose us?

Pass an Audit?

Maryland Patent of the Month – April 2025

May 6, 2025 Maryland Patent of the Month, Pharmaceutical

Theriva Biologics, Inc. has earned U.S. Patent No. 12,274,740, titled “Microbiome Protection from Oral Antibiotics.” This new invention aims to protect the gut during antibiotic use—offering a [...]

Pharmaceutical Case Study

Pharmaceutical companies are constantly working to develop innovative medicines and therapies that improve patient outcomes and address unmet medical needs. This process involves extensive research and development (R&D), including drug discovery, chemical synthesis, preclinical testing, and clinical trials. However, these efforts are often extremely costly and time-consuming, with no guarantee of success. R&D tax credits offer a critical financial incentive that helps pharmaceutical companies offset some of these high costs, allowing them to reinvest in further innovation. By reducing the effective cost of research activities, these credits enable companies to pursue more ambitious and risk-intensive projects that might otherwise be financially unfeasible. For the pharmaceutical industry, R&D tax credits can significantly accelerate the pace of innovation. They encourage continued investment in new drug development, support the creation of cutting-edge treatments, and foster collaboration with academic institutions, research centers, and biotechnology startups. Additionally, these credits can enhance a company’s global competitiveness by improving cash flow and reducing tax liabilities, which is particularly valuable in a sector where long development timelines and regulatory hurdles can delay returns on investment. In a rapidly evolving healthcare landscape, where demand for effective and personalized medicine is growing, the R&D tax credit plays a vital role in sustaining pharmaceutical advancement. It not only supports the discovery of life-saving treatments but also contributes to job creation, economic growth, and improved public health. Overall, the R&D tax credit is a powerful tool that fuels innovation and strengthens the pharmaceutical industry’s ability to deliver better healthcare solutions to society.